Arcadia Biosciences (RKDA) Non-Current Assets (2014 - 2025)

Arcadia Biosciences' Non-Current Assets history runs 12 years deep, the most recent figure standing at $190000.0 for Q4 2025.

• Quarterly Non-Current Assets fell 95.56% year-over-year to $190000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.7 million (down 73.88% YoY) and the FY2025 annual result came in at $190000.0, down 95.56% from the prior year.
• Non-Current Assets was $190000.0 for Q4 2025 at Arcadia Biosciences, down from $197000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $19.9 million in Q2 2021 and bottomed at $190000.0 in Q4 2025.
• A 5-year average of $5.8 million and a median of $4.4 million in 2022 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2021 — Non-Current Assets jumped 70.19% — and 2025, when it tumbled 95.76%.
• Arcadia Biosciences' Non-Current Assets stood at $8.5 million in 2021, then slumped by 58.69% to $3.5 million in 2022, then soared by 34.31% to $4.7 million in 2023, then retreated by 9.68% to $4.3 million in 2024, then tumbled by 95.56% to $190000.0 in 2025.
• Business Quant data shows RKDA's Non-Current Assets at $190000.0 in Q4 2025, $197000.0 in Q3 2025, and $209000.0 in Q2 2025.